Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LN Gonzalez Castro, S McBrayer… - Neuro …, 2023 - academic.oup.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LNG Castro, S McBrayer… - Neuro …, 2023 - scholars.northwestern.edu
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LNG Castro, S McBrayer… - Neuro …, 2023 - pubmed.ncbi.nlm.nih.gov
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
JJ Miller, C Horbinski, J Portnow, IK Mellinghoff… - Neuro …, 2023 - inrepo02.dkfz.de
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
JJ Miller, GC LN, S McBrayer, M Weller… - Neuro …, 2023 - europepmc.org
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LNG Castro, S McBrayer… - Neuro …, 2023 - mayoclinic.elsevierpure.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
[HTML][HTML] Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LNG Castro, S McBrayer, M Weller… - Neuro …, 2023 - ncbi.nlm.nih.gov
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LNG Castro, S McBrayer… - Neuro …, 2023 - utsouthwestern.elsevierpure.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
J Miller, L Gonzalez Castro, S McBrayer… - Neuro …, 2023 - escholarship.org
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
JJ Miller, LN Gonzalez Castro, S McBrayer, M Weller… - Neuro-Oncology, 2023 - zora.uzh.ch
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …
primary brain tumors diagnosed in patients younger than 50, constituting an important cause …